The Nordic Aortic Valve Intervention (NOTION) trial comparing transcatheter versus surgical valve implantation: Study protocol for a randomised controlled trial

Trials

Volumn 14, Issue 1, 2013, Pages

  Thyregod, Hans Gustav ^a   Søndergaard, Lars ^a   Ihlemann, Nikolaj ^a   Franzen, Olaf ^a   Andersen, Lars Willy ^a   Hansen, Peter Bo ^a   Olsen, Peter Skov ^a   Nissen, Henrik ^b   Winkel, Per ^a   Gluud, Christian ^a   Steinbrüchel, Daniel Andreas ^a  

^a University of Copenhagen   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Aortic valve prosthesis; Aortic valve stenosis; Randomised clinical trial design; Surgical aortic valve replacement; Transcatheter aortic valve implantation

Indexed keywords

AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CEREBROVASCULAR ACCIDENT; HEART INFARCTION; HEART PERFORMANCE; HUMAN; INTERMETHOD COMPARISON; MORTALITY; MULTICENTER STUDY (TOPIC); QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SURGICAL AORTIC VALVE REPLACEMENT; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AORTIC VALVE STENOSIS; BIOPROSTHESIS; CARDIAC CATHETERIZATION; CLINICAL PROTOCOLS; DENMARK; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; QUALITY OF LIFE; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; SWEDEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872037856     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-11     Document Type: Article

References (37)

1. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003, 24:1231-1243. 10.1016/S0195-668X(03)00201-X, 12831818.
2. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006, 368:1005-1011. 10.1016/S0140-6736(06)69208-8, 16980116.
3. Ross J, Braunwald E. Aortic stenosis. Circulation 1968, 38:61-67.
4. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A, . Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology ESC Committee for Practice Guidelines Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of cardiology. Eur Heart J 2007, 28:230-268. Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology ESC Committee for Practice Guidelines.
5. Vahanian A, Iung B. The new ESC/EACTS guidelines on the management of valvular heart disease. Arch Cardiovasc Dis 2012, 105:465-467. 10.1016/j.acvd.2012.09.001, 23062477.
6. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, Gohlke-Bärwolf C, Boersma E, Ravaud P, Vahanian A. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?. Eur Heart J 2005, 26:2714-2720. 10.1093/eurheartj/ehi471, 16141261.
7. O'Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP, . Society of Thoracic Surgeons Quality Measurement Task Force The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery. Ann Thorac Surg 2009, 88:S23-S42. 10.1016/j.athoracsur.2009.05.056, 19559823, Society of Thoracic Surgeons Quality Measurement Task Force.
8. Roques F, Nashef SA, Michel P. Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J Heart Valve Dis 2001, 10:572-577. discussion 577-578.
9. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. EuroSCORE II. Eur J Cardiothorac Surg 2012, 41:734-744. discussion 744-735, 10.1093/ejcts/ezs043, 22378855.
10. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992, 13:704-708.
11. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002, 106:3006-3008. 10.1161/01.CIR.0000047200.36165.B8, 12473543.
12. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, Nusimovici D, Litzler PY, Bessou JP, Leon MB. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004, 43:698-703. 10.1016/j.jacc.2003.11.026, 14975485.
13. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006, 114:1616-1624. 10.1161/CIRCULATIONAHA.106.639450, 17015786.
14. Kahlert P, Knipp SC, Schlamann M, Thielmann M, Al-Rashid F, Weber M, Johansson U, Wendt D, Jakob HG, Forsting M, Sack S, Erbel R, Eggebrecht H. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 2010, 121:870-878. 10.1161/CIRCULATIONAHA.109.855866, 20177005.
15. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrié D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012, 366:1705-1715. 10.1056/NEJMoa1114705, 22551129.
16. Webb J, Cribier A. Percutaneous transarterial aortic valve implantation: what do we know?. Eur Heart J 2011, 32:140-147. 10.1093/eurheartj/ehq453, 21131653.
17. Tzikas A, van Dalen BM, Van Mieghem NM, Gutierrez-Chico JL, Nuis RJ, Kauer F, Schultz C, Serruys PW, de Jaegere PP, Geleijnse ML. Frequency of conduction abnormalities after transcatheter aortic valve implantation with the Medtronic-CoreValve and the effect on left ventricular ejection fraction. Am J Cardiol 2011, 107:285-289. 10.1016/j.amjcard.2010.09.015, 21129715.
18. Olsen LK, Engstrøm T, Wachtell K, Kristensen T, Hassager C, Ihlemann N, Møller JE, Andersen LW, Olsen PS, Søndergaard L. Percutaneous aortic valve replacement - initial experience and results. Ugeskr Laeger 2009, 171:1289-1293.
19. Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP, Thomas M, Kovac J, Spyt T, MacCarthy PA, Wendler O, Hildick-Smith D, Davies SW, Trivedi U, Blackman DJ, Levy RD, Brecker SJ, Baumbach A, Daniel T, Gray H, Mullen MJ. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: The U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) registry. J Am Coll Cardiol 2011, 58:2130-2138. 10.1016/j.jacc.2011.08.050, 22019110.
20. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007, 50:69-76. 10.1016/j.jacc.2007.04.047, 17601548.
21. Hammerstingl C, Nickenig G, Grube E. Treatment of a degenerative stenosed CoreValve® aortic bioprosthesis by transcatheter valve-in-valve insertion. Catheter Cardiovasc Interv 2012, 79:748-755. 10.1002/ccd.23228, 21735534.
22. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S, . PARTNER Trial Investigators Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010, 363:1597-1607. 10.1056/NEJMoa1008232, 20961243, PARTNER Trial Investigators.
23. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ, . PARTNER Trial Investigators Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011, 364:2187-2198. 10.1056/NEJMoa1103510, 21639811, PARTNER Trial Investigators.
24. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB, . PARTNER Trial Investigators Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012, 366:1696-1704. 10.1056/NEJMoa1202277, 22443478, PARTNER Trial Investigators.
25. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB, . PARTNER Trial Investigators Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012, 366:1686-1695. 10.1056/NEJMoa1200384, 22443479, PARTNER Trial Investigators.
26. Nielsen HH, Klaaborg KE, Nissen H, Terp K, Mortensen PE, Kjeldsen BJ, Jakobsen CJ, Andersen HR, Egeblad H, Krusell LR, Thuesen L, Hjortdal VE. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial. EuroIntervention 2012, 8:383-389. 10.4244/EIJV8I3A58, 22581299.
27. Vahanian A, Alfieri OR, Al-Attar N, Antunes MJ, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr FW, Nataf P, Pierard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, von Segesser LK, Walther T. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg 2008, 34:1-8. 10.1016/j.ejcts.2008.04.039, 18502659.
28. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999, 46:263-268.
29. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006, 53:441-449.
30. Helweg-Larsen K. The Danish register of causes of death. Scand J Public Health 2011, 39:26-29.
31. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 2011, 32:205-217. 10.1093/eurheartj/ehq406, 3021388, 21216739.
32. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 2012, 42:S45-S60. 10.1093/ejcts/ezs533, 23026738.
33. Dvir D, Webb J, Brecker S, Bleiziffer S, Hildick-Smith D, Colombo A, Descoutures F, Hengstenberg C, Moat NE, Bekeredjian R, Napodano M, Testa L, Lefevre T, Guetta V, Nissen H, Hernández JM, Roy D, Teles RC, Segev A, Dumonteil N, Fiorina C, Gotzmann M, Tchetche D, Abdel-Wahab M, De Marco F, Baumbach A, Laborde JC, Kornowski R. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation 2012, 126:2335-2344. 10.1161/CIRCULATIONAHA.112.104505, 23052028.
34. Thyregod HG, Lund JT, Engstrøm T, Steinbrüchel DA. Transcatheter aortic valve prosthesis surgically replaced 4 months after implantation. Eur J Cardiothorac Surg 2010, 37:494-496.
35. Ussia GP, Scarabelli M, Mulè M, Barbanti M, Sarkar K, Cammalleri V, Immè S, Aruta P, Pistritto AM, Gulino S, Deste W, Capodanno D, Tamburino C. Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 2011, 108:1772-1776. 10.1016/j.amjcard.2011.07.049, 21907949.
36. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, Gluud C, Martin RM, Wood AJ, Sterne JA. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008, 336:601-605. 10.1136/bmj.39465.451748.AD, 2267990, 18316340.
37. Savovic J, Jones HE, Altman DG, Altman DG, Harris RJ, Jüni P, Pildal J, Als-Nielsen B, Balk EM, Gluud C, Gluud LL, Ioannidis JP, Schulz KF, Beynon R, Welton NJ, Wood L, Moher D, Deeks JJ, Sterne JA. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med 2012, 157:429-438.